help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uckaya, G.
Right arrow Articles by Ozdemir, I. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uckaya, G.
Right arrow Articles by Ozdemir, I. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Retinal Disorders
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 683-687
Copyright © 2000 by The Endocrine Society


Original Studies

Is Leptin Associated with Hypertensive Retinopathy?1

Gokhan Uckaya, Metin Ozata, Alper Sonmez, Can Kinalp, Tayfun Eyileten, Necati Bingol, Bayram Koc, Fikri Kocabalkan and I. Caglayan Ozdemir

Departments of Endocrinology and Metabolism (G.U., M.O., I.C.O.) and Internal Medicine (A.S., C.K., T.E., B.K., F.K.), Gulhane School of Medicine, Etlik-Ankara 06018; and Bayindir Medical Center (N.B.), Sogutozu-Ankara 06520, Turkey

Address all correspondence and requests for reprints to: Metin Ozata, M.D., Department of Endocrinology and Metabolism, Gulhane School of Medicine, Etlik-Ankara 06018, Turkey. E-mail: mozata{at}obs.gata.edu.tr

Previous studies have demonstrated that elevated plasma leptin concentrations are associated with essential hypertension. It has also recently been shown that leptin plays a promoting role in angiogenesis, and the vascular endothelium expresses the long form of leptin receptor. Those data led us to hypothesize that leptin might contribute to end-organ damage in hypertension. Thus, in the present study we evaluated the relationship between plasma leptin concentrations and hypertensive retinopathy (HR). One hundred and eleven patients newly diagnosed with essential hypertension [EHT; mean age, 43.5 ± 10.7 yr; body mass index (BMI), 28.1 ± 4.4 kg/m2; male/female ratio, 71/40] and 79 healthy normotensive control subjects (NT; mean age, 43.6 ± 9.2 yr; BMI, 28.2 ± 3.3 kg/m2; male/female ratio, 50/29) were enrolled in the study. For the assessment of retinopathy according to the Keith-Wagener classification, direct and indirect ophthalmoscopy were performed in all subjects after dilatation of the pupils. Plasma leptin levels were significantly higher in EHT (11.8 ± 11.1 ng/mL) than in NT (7.2 ± 5.1ng/mL) (P = 0.003). Plasma leptin concentrations were strongly correlated with BMI in both EHT (r = 0.45; P = 0.001) and NT (r = 0.38; P = 0.001) groups. Plasma leptin in patients with grade 2 HR (24.8 ± 15.8 ng/mL; n = 22) was significantly higher than that in patients with grade 1 HR (16.1 ± 4.9 ng/mL; n = 29; P = 0.001), grade 0 HR (5.1 ± 3.1 ng/mL; n = 60; P = 0.001), and NT (P = 0.001). Plasma leptin in patients with grade 1 HR was also significantly higher than that in patients without retinopathy (P = 0.001) or in NT (P = 0.001). The estimated threshold of plasma leptin concentration for HR was 10.2 ng/mL. This critical leptin level served largely to separate patients with retinopathy from those without retinopathy. In summary, our results show that plasma leptin concentrations increase progressively with higher grades of hypertensive retinopathy even after correction for BMI, suggesting that a critical leptin level is needed for the development of retinopathy. Elevated concentrations of plasma leptin might be secondary to release of leptin by the vascular endothelium damaged by high blood pressure, as an epiphenomenon. However, a pathogenic role for leptin in hypertensive retinopathy cannot be excluded.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. I. Yilmaz, A. Sonmez, S. Kilic, T. Celik, N. Bingol, M. Pinar, T. Mumcuoglu, and M. Ozata
The association of plasma adiponectin levels with hypertensive retinopathy
Eur. J. Endocrinol., February 1, 2005; 152(2): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Gomez-Ambrosi, J. Salvador, and G. Fruhbeck
Is hyperleptinemia involved in the development of age-related lens opacities?
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 888 - 889.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society